Palvella Awarded Up to $2.6 million Grant from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development to Support Phase 3 Single-Arm, Baseline-Controlled Trial in Microcystic Lymphatic Malformations FDA Orphan Products Grants are based on scientific and technical merit as determined by rare disease and regulatory experts …
Read More
Wellsheet and Wolters Kluwer Collaborate to Integrate AI-Powered Clinical Workflows with UpToDate See more here
Read More
IVIEW Therapeutics Inc. Completes Patient Recruitment for Phase 1/2 Trial of IVW-1001 Ophthalmic Eyelid Wipe in Dry Eye Disease Patients See more here
Read More
The pathogenic role of retinoid nuclear receptor signaling in cancer and metabolic syndromes See more here
Read More
Phrase Health Secures NIH SBIR Funding to Advance Innovative Analytics Solutions Phrase Health, Inc. secures $2M NIH SBIR grant to develop innovative EHR workflow management solutions, advancing patient care through data-driven, continuous improvement. See more here
Read More
Delve Health Partners with Strados Labs to Enhance Remote Patient Monitoring in Clinical Trials See more here
Read More
Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement Proposed merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for serious, rare genetic skin diseases for which there are no FDA-approved therapies Combined company is expected to have approximately $80.5 million of cash and…
Read More
Strados Labs announces successful completion of pediatric asthma study See more here
Read More
Vittoria Biotherapeutics Announces Peer-Reviewed Publication in Science Immunology See more here
Read More
Accelerated Bio and Pluristyx create Clinical Grade Induced Pluripotent Stem Cells from Reprogramming Human Trophoblast Stem Cells See more here
Read More